vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and RLJ Lodging Trust (RLJ). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $328.6M, roughly 1.5× RLJ Lodging Trust). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.1%, a 6.7% gap on every dollar of revenue. On growth, RLJ Lodging Trust posted the faster year-over-year revenue change (-0.4% vs -1.7%). Over the past eight quarters, RLJ Lodging Trust's revenue compounded faster (0.6% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

The RLJ Companies is an American asset management firm owned by entrepreneur Robert Louis Johnson. After selling Black Entertainment Television in 2001, Johnson's first company, he created RLJ Companies in Bethesda, Maryland. The company's network includes hotel real estate investment, private equity, financial services, asset management, insurance services, car dealerships, sports and entertainment, and video lottery terminal (VLT) gaming. The company is headquartered in Bethesda and has add...

MD vs RLJ — Head-to-Head

Bigger by revenue
MD
MD
1.5× larger
MD
$493.8M
$328.6M
RLJ
Growing faster (revenue YoY)
RLJ
RLJ
+1.3% gap
RLJ
-0.4%
-1.7%
MD
Higher net margin
MD
MD
6.7% more per $
MD
6.8%
0.1%
RLJ
Faster 2-yr revenue CAGR
RLJ
RLJ
Annualised
RLJ
0.6%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
RLJ
RLJ
Revenue
$493.8M
$328.6M
Net Profit
$33.7M
$430.0K
Gross Margin
Operating Margin
9.9%
0.2%
Net Margin
6.8%
0.1%
Revenue YoY
-1.7%
-0.4%
Net Profit YoY
10.5%
-92.0%
EPS (diluted)
$0.40
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
RLJ
RLJ
Q4 25
$493.8M
$328.6M
Q3 25
$492.9M
$330.0M
Q2 25
$468.8M
$363.1M
Q1 25
$458.4M
$328.1M
Q4 24
$502.4M
$330.0M
Q3 24
$511.2M
$345.7M
Q2 24
$504.3M
$369.3M
Q1 24
$495.1M
$324.4M
Net Profit
MD
MD
RLJ
RLJ
Q4 25
$33.7M
$430.0K
Q3 25
$71.7M
$-3.7M
Q2 25
$39.3M
$28.5M
Q1 25
$20.7M
$3.4M
Q4 24
$30.5M
$5.4M
Q3 24
$19.4M
$20.6M
Q2 24
$-153.0M
$37.1M
Q1 24
$4.0M
$4.9M
Operating Margin
MD
MD
RLJ
RLJ
Q4 25
9.9%
0.2%
Q3 25
13.8%
-1.0%
Q2 25
12.8%
8.0%
Q1 25
7.0%
1.1%
Q4 24
7.8%
1.8%
Q3 24
6.6%
6.1%
Q2 24
-31.3%
10.2%
Q1 24
3.2%
1.6%
Net Margin
MD
MD
RLJ
RLJ
Q4 25
6.8%
0.1%
Q3 25
14.5%
-1.1%
Q2 25
8.4%
7.8%
Q1 25
4.5%
1.0%
Q4 24
6.1%
1.6%
Q3 24
3.8%
6.0%
Q2 24
-30.3%
10.0%
Q1 24
0.8%
1.5%
EPS (diluted)
MD
MD
RLJ
RLJ
Q4 25
$0.40
$-0.05
Q3 25
$0.84
$-0.07
Q2 25
$0.46
$0.15
Q1 25
$0.24
$-0.02
Q4 24
$0.37
$-0.01
Q3 24
$0.23
$0.09
Q2 24
$-1.84
$0.20
Q1 24
$0.05
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
RLJ
RLJ
Cash + ST InvestmentsLiquidity on hand
$375.2M
$410.2M
Total DebtLower is stronger
$570.5M
$2.2B
Stockholders' EquityBook value
$865.9M
$2.2B
Total Assets
$2.2B
$4.7B
Debt / EquityLower = less leverage
0.66×
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
RLJ
RLJ
Q4 25
$375.2M
$410.2M
Q3 25
$340.1M
$374.8M
Q2 25
$224.7M
$373.9M
Q1 25
$99.0M
$347.5M
Q4 24
$229.9M
$409.8M
Q3 24
$103.8M
$385.4M
Q2 24
$19.4M
$371.1M
Q1 24
$8.0M
$350.2M
Total Debt
MD
MD
RLJ
RLJ
Q4 25
$570.5M
$2.2B
Q3 25
$577.2M
$2.2B
Q2 25
$583.9M
$2.2B
Q1 25
$590.5M
$2.2B
Q4 24
$597.1M
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
MD
MD
RLJ
RLJ
Q4 25
$865.9M
$2.2B
Q3 25
$890.7M
$2.2B
Q2 25
$833.8M
$2.2B
Q1 25
$789.2M
$2.2B
Q4 24
$764.9M
$2.3B
Q3 24
$732.5M
$2.3B
Q2 24
$706.5M
$2.3B
Q1 24
$856.2M
$2.3B
Total Assets
MD
MD
RLJ
RLJ
Q4 25
$2.2B
$4.7B
Q3 25
$2.2B
$4.8B
Q2 25
$2.1B
$4.8B
Q1 25
$2.0B
$4.8B
Q4 24
$2.2B
$4.9B
Q3 24
$2.1B
$4.9B
Q2 24
$2.0B
$4.9B
Q1 24
$2.2B
$4.9B
Debt / Equity
MD
MD
RLJ
RLJ
Q4 25
0.66×
1.01×
Q3 25
0.65×
1.01×
Q2 25
0.70×
1.00×
Q1 25
0.75×
0.99×
Q4 24
0.78×
0.97×
Q3 24
0.96×
Q2 24
0.95×
Q1 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
RLJ
RLJ
Operating Cash FlowLast quarter
$114.1M
$243.8M
Free Cash FlowOCF − Capex
$117.4M
FCF MarginFCF / Revenue
35.7%
Capex IntensityCapex / Revenue
38.5%
Cash ConversionOCF / Net Profit
3.39×
566.97×
TTM Free Cash FlowTrailing 4 quarters
$186.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
RLJ
RLJ
Q4 25
$114.1M
$243.8M
Q3 25
$137.3M
$63.3M
Q2 25
$137.2M
$101.3M
Q1 25
$-117.5M
$16.3M
Q4 24
$133.0M
$285.4M
Q3 24
$91.8M
$80.1M
Q2 24
$107.0M
$113.5M
Q1 24
$-125.2M
$20.8M
Free Cash Flow
MD
MD
RLJ
RLJ
Q4 25
$117.4M
Q3 25
$33.6M
Q2 25
$66.1M
Q1 25
$-30.5M
Q4 24
$148.9M
Q3 24
$45.4M
Q2 24
$74.9M
Q1 24
$-13.0M
FCF Margin
MD
MD
RLJ
RLJ
Q4 25
35.7%
Q3 25
10.2%
Q2 25
18.2%
Q1 25
-9.3%
Q4 24
45.1%
Q3 24
13.1%
Q2 24
20.3%
Q1 24
-4.0%
Capex Intensity
MD
MD
RLJ
RLJ
Q4 25
38.5%
Q3 25
9.0%
Q2 25
9.7%
Q1 25
14.3%
Q4 24
41.4%
Q3 24
10.0%
Q2 24
10.4%
Q1 24
10.4%
Cash Conversion
MD
MD
RLJ
RLJ
Q4 25
3.39×
566.97×
Q3 25
1.91×
Q2 25
3.49×
3.56×
Q1 25
-5.66×
4.85×
Q4 24
4.36×
53.09×
Q3 24
4.72×
3.89×
Q2 24
3.06×
Q1 24
-31.03×
4.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

RLJ
RLJ

Occupancy$262.1M80%
Food And Beverage$41.9M13%
Hotel Other$24.6M7%

Related Comparisons